
P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY‐DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE
Author(s) -
Botton S.,
Choe S.,
Marchione D.,
Montesinos P.,
Recher C.,
Vives Polo S.,
Zarzycka E.,
Wang J.,
Bertani G.,
Heuser M.,
Calado R.,
Schuh A.,
Yeh S.P.,
Hui J.,
Pandya S.,
Gianolio D.,
Daigle S.,
DiNardo C.,
Dohner H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844608.72364.51
Subject(s) - idh1 , isocitrate dehydrogenase , myeloid leukemia , medicine , peripheral blood mononuclear cell , bone marrow , azacitidine , placebo , oncology , gastroenterology , mutation , biology , pathology , genetics , biochemistry , gene expression , dna methylation , alternative medicine , gene , in vitro , enzyme